Considering the molecular heterogeneity of PCa in particular, the selection of the group of tumors characterized by the TMPRSS2-ERG fusion transcript allows researchers to focus on specific molecular subtypes of PCa and, therefore, form a more homogeneous group of PCa cases. The gene discussed is TMPRSS2; the disease is posterior cortical atrophy.